Young adults need affordable health insurance

One fact during the health insurance debate that just about everyone can agree on is bringing more young adults into the health care system. This would help balance out the cost for everyone because young adults generally use the least amount of care. Supporters of the health care reform say that young American citizens will be among the largest beneficiaries of changes that promise to bring more affordable health insurancealternatives to the individual market. Health care is a hot topic for college students who worry about post graduation jobs and their ability to receive employer supplied health insurance. Do you think by recruiting more young people into the health care system will lower health insurance cost for everyone?

We all need health insurance. Having a solid health policy in place helps
pay for the high medical bills that come with doctor visits,
operations, and medicine. Having health insurance can mean the
difference between getting treatment but still living comfortably or
getting treatment and running out of money.

Our health insurance policies assist you in paying for doctor visits, prescriptions,

necessary types of testing, specialist care, and surgical procedures.

We at Headquarter Insurance Group want to provide you with the best health
insurance advice and most competitive products available. Whether
you’re looking for individual coverage, group coverage for a business,
long term care, or any other type of health insurance, we’ll help
design an insurance program for you!



Contact us today or fill out our quick online health insurance form for more information!

Or call: 1-888-842-9430

Vaccines on Horizon for AIDS, Alzheimer's, Herpes

Associated Press
Linda A. Johnson

Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.

Many could be on the market in five years or less.

Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of factory contamination at one of the two manufacturers left.

Vaccines are no longer a sleepy, low-profit niche in a booming drug industry. Today, they're starting to give ailing pharmaceutical makers a shot in the arm.

The lure of big profits, advances in technology and growing government support has been drawing in new companies, from nascent biotechs to Johnson & Johnson. That means recent remarkable strides in overcoming dreaded diseases and annoying afflictions likely will continue.

"Even if a small portion of everything that's going on now is successful in the next 10 years, you put that together with the last 10 years (and) it's going to be characterized as a golden era," says Emilio Emini, Pfizer Inc.'s head of vaccine research.

Vaccines now are viewed as a crucial path to growth, as drugmakers look for ways to bolster slowing prescription medicine sales amid intensifying generic competition and government pressure to cut down prices under the federal health overhaul.

Unlike medicines that treat diseases, vaccines help prevent infections by revving up the body's natural immune defenses against invaders. They are made from viruses, bacteria or parts of them that have been killed or weakened so they generally can't cause an infection.

Investment in partnerships and other deals to develop and manufacture vaccines has been on a tear -- and accelerating since the swine flu pandemic began. Billions in government grants are bringing better, faster ways to develop and manufacture vaccines. Rising worldwide emphasis on preventive health care, plus the advent of the first multibillion-dollar vaccines, have further boosted their appeal.

Read more.........